| Patents for B82Y 5 - Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery (2,162) |
|---|
| 02/09/2012 | US20120034291 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications |
| 02/09/2012 | US20120034286 Stabilization of biosolids using iron nanoparticles |
| 02/09/2012 | US20120034278 Ophthalmic preparation containing menthyl ester of indomethacin |
| 02/09/2012 | US20120034162 Fullerene Assisted Cell Penetrating Peptides |
| 02/09/2012 | US20120034156 Artificial cells |
| 02/09/2012 | US20120034155 Artificial cells |
| 02/08/2012 | CN102343098A Functionalized magnetic nanoparticles and methods of use thereof |
| 02/02/2012 | US20120029331 Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using electrodes with microvoltammetry |
| 02/02/2012 | US20120029064 formulation of silibinin with high efficacy and prolonged action and the preparation method thereof |
| 02/02/2012 | US20120028267 Method for increasing sensitivity using linker and spacer in carbon nanotube-based biosensor |
| 02/02/2012 | US20120027865 Water Dispersible Glyceryl Monooleate Magnetic Nanoparticle Formulation |
| 02/02/2012 | US20120027859 Biodegradable Proline-Based Polymers |
| 02/02/2012 | US20120027830 Cosmetic |
| 02/02/2012 | US20120027821 Amino acid-conjugated cyanoacrylate polymer particles |
| 02/02/2012 | US20120027809 Pharmaceutical compositions comprising water-soluble sulfonate-protected nanoparticles and uses thereof |
| 02/02/2012 | US20120027808 Nicotine immunonanotherapeutics |
| 02/02/2012 | US20120027806 Dose selection of adjuvanted synthetic nanocarriers |
| 02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
| 02/02/2012 | US20120027681 Low-Aspect Ratio Carbon Nanostructures |
| 02/01/2012 | EP1353699B1 Beta-cyclodextrin-drospirenone inclusion complexes |
| 01/26/2012 | US20120023620 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/26/2012 | US20120023619 Linear dna molecule delivery using pegylated quantum dots for stable trasformation in plants |
| 01/26/2012 | US20120021055 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 01/26/2012 | US20120021050 Nanoparticle formulated glycolipid antigens for immunotherapy |
| 01/26/2012 | US20120021044 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same |
| 01/26/2012 | US20120021036 Composite nanostructures and methods for making and using them |
| 01/26/2012 | US20120021035 Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof |
| 01/26/2012 | US20120021034 Structured silver-mesoporous silica nanoparticles having antimicrobial activity |
| 01/26/2012 | US20120021016 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/26/2012 | US20120021012 Novel pharmaceutical uses for nanoparticles |
| 01/26/2012 | US20120021010 Antiplatelet agent and methods of using the same |
| 01/26/2012 | US20120020894 Production of Targeted MRI Probes by Biocompatible Coupling of Macromolecules with Charged Nanoparticles |
| 01/26/2012 | US20120020879 Process, composition and method for anion deposition into ferritin for therapeutic and other use |
| 01/26/2012 | US20120018301 Nanoelectronic electrochemical test device |
| 01/19/2012 | WO2011106459A3 Analyte sequencing with nanopores |
| 01/19/2012 | WO2011033040A3 Antibacterial particles and their synthesis |
| 01/19/2012 | US20120015035 Implantable Delivery Vehicle for Ocular Delivery of Muscarinic Antagonists |
| 01/19/2012 | US20120015004 Encapsulated salts and use in high acid beverages |
| 01/19/2012 | US20120015001 Methods of treating thyroid eye disease |
| 01/19/2012 | US20120015000 Malaria vaccine of self-assembling polypeptide nanoparticles |
| 01/12/2012 | WO2012006443A2 Linear dna molecule delivery using pegylated quantum dots for stable transformation in plants |
| 01/12/2012 | WO2012006439A2 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/12/2012 | WO2011113054A3 Crosslinked polynucleotide structure |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120009260 Nanoparticle film delivery systems |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009252 Liposomal formulations of anthracycline agents and cytidine analogs |
| 01/12/2012 | US20120009223 COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES |
| 01/12/2012 | US20120009222 Modulation of the immune response |
| 01/12/2012 | US20120009130 Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques |
| 01/12/2012 | CA2804168A1 Linear dna molecule delivery using pegylated quantum dots for stable transformation in plants |
| 01/12/2012 | CA2804164A1 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/11/2012 | EP2404608A1 Combination use of cholestanol derivative |
| 01/05/2012 | US20120004531 Innately Multimodal Nanoparticles |
| 01/05/2012 | US20120004308 Method for obtaining solid micro- or nanoparticles |
| 01/05/2012 | US20120004293 Cancer Cell Targeting Using Nanoparticles |
| 01/05/2012 | US20120004181 Targeted delivery system |
| 01/05/2012 | US20120003710 Isolation of Biomolecules from Biological Samples |
| 01/05/2012 | US20120003321 Crosslinked Dextran Composite Magnetic Microparticles and Preparation Process and Using Method Thereof |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003278 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 12/29/2011 | WO2011162366A1 Water-soluble polymer and water-soluble nanoparticle composite |
| 12/29/2011 | US20110319342 CELL-SPECIFICALLY EFFECTIVE MOLECULES ON THE BASIS OF siRNA AND APPLICATION KITS FOR THE PRODUCTION THEREOF AND USE THEREOF |
| 12/29/2011 | US20110318415 Hollow Gold Nanospheres (HAuNSs) and HAuNSs-Loaded Microspheres Useful in Drug Delivery |
| 12/29/2011 | US20110318414 Regenerative tissue grafts and methods of making same |
| 12/29/2011 | US20110318267 Ph-responsive nanostructures |
| 12/29/2011 | CA2802433A1 Water-soluble polymer and water-soluble nanoparticle composite |
| 12/28/2011 | EP2399610A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 12/28/2011 | EP2170332B1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 12/22/2011 | US20110312899 HDL Particles for Delivery of Nucleic Acids |
| 12/22/2011 | US20110312877 Engineered tunable nanoparticles for delivery of therapeutics, diagnostics, and experimental compounds and related compositions for therapeutic use |
| 12/22/2011 | US20110311647 Biofilm-removing antimicrobial compositions and uses thereof |
| 12/22/2011 | US20110311639 Facile Route to the Synthesis of Resorcinarene Nanocapsules |
| 12/22/2011 | US20110311635 Hollow metal oxide spheres and nanoparticles encapsulated therein |
| 12/22/2011 | US20110311616 Targeting tumor associated macrophages using bisphosphonate-loaded particles |
| 12/22/2011 | US20110311613 Topical formulations of flap inhibitors for the treatment of dermatological conditions |
| 12/22/2011 | US20110311596 Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same |
| 12/22/2011 | US20110311505 Photosensitive Aminoacid-Monomer Linkage and Bioconjugation Applications in Life Sciences and Biotechnology |
| 12/22/2011 | US20110311457 Methods for imaging vascular inflammation using improved nanoparticle contrast agents |
| 12/22/2011 | US20110311453 Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto |
| 12/22/2011 | US20110311452 Inflammation targeting particles |
| 12/22/2011 | US20110311442 Direct cellular energy delivery system |
| 12/15/2011 | US20110306699 In situ formation of nanoparticles in resins |
| 12/15/2011 | US20110306084 Tritiated Planar Carbon Forms |
| 12/15/2011 | US20110305770 Releasable polymeric lipids for nucleic acids delivery system |
| 12/15/2011 | US20110305769 Branched cationic lipids for nucleic acids delivery system |
| 12/15/2011 | US20110305768 Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
| 12/15/2011 | US20110305765 Preparation and methodology of silk fibroin nanoparticles |
| 12/15/2011 | US20110305749 HIV-1 Envelope Polypeptides for HIV Vaccine |
| 12/15/2011 | US20110305734 Nucleic acid nanoparticles and uses therefor |
| 12/14/2011 | EP2394639A1 Hyperthermic technologies and therapeutic uses thereof |
| 12/08/2011 | US20110301452 Microcapsule for local treatment of a tumor and method for positioning a magnetic gradient field guiding magnetic nanoparticles to a target location as well as apparatus for positioning a magnetic gradient field |
| 12/08/2011 | US20110300532 Control of the toxicity of gold nanoparticles |
| 12/08/2011 | US20110300251 Device for the execution of the output of nanoscaled polymer fibers |
| 12/08/2011 | US20110300239 Blood flow improving agent |
| 12/08/2011 | US20110300222 Luminescent porous silicon nanoparticles, methods of making and using same |
| 12/08/2011 | US20110300126 Dispersion and debundling of carbon nanotubes using gemini surfactant compounds |
| 12/07/2011 | CN102266219A Spectral imaging of deep tissue |
| 12/01/2011 | WO2011147926A2 Magnetically responsive membrane structures |